Moderna Therapeutics Stock
Moderna Therapeutics specializes in drug discovery and drug development based on messenger RNA.
Sign up today and learn more about Moderna Therapeutics Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Moderna Therapeutics Stock
Moderna Therapeutics develops messenger RNA therapeutics. Itprovides in vivo drug modality that produces human proteins or antibodies inside patient cells. Moderna Therapeutics also develops various patent applications with various claims ranging from novel nucleotide chemistries to specific drug compositions. It focuses on disease areas, such as inherited genetic disorders, hemophilic and blood factors, and oncology.
Investors
Sequoia Capital
Market Kurly, Robinhood, Airbnb, Instacart, Tokopedia, Stripe, DoorDash, Rappi, CoinSwitch Kuber, UiPath
Viking Global Investors
Impossible Foods, Moderna Therapeutics, Apeel Sciences, Adaptive Biotechnologies, Arctic Wolf, Talkdesk, Druva, Color, Clip, Iterable
Wellington Management Company
Magic Leap, Moderna Therapeutics, Compass, Pinterest, Oscar Health, Dataminr, DocuSign, Lookout, Sprinklr, PagerDuty
Funding History
| December 2012 | $40.0M |
|---|---|
| October 2013 | $24.6M |
| November 2013 | $110M |
| January 2014 | $25.0M |
| January 2015 | $450M |
| January 2016 | $20.0M |
| August 2016 | $474M |
| September 2016 | $8.0M |
| February 2018 | $500M |
| May 2018 | $125M |
Management
Chief Executive Officer
Stéphane Bancel
President
Stephen Hoge
Chief Financial Officer
Lorence Kim
Chief Digital Officer
Marcello Damiani
Chief Human Resources Officer
Annie Drapeau
Chief Sustainability Officer and Chief of Staff
Stephen Harbin
Chief Corporate Affairs Officer
Megan Pace
Chief Medical Officer
Tal Zaks
Press
Wall Streets Journal - Mar, 16 2020
Human Testing Begins Earlier Than Expected For U.S. Coronavirus VaccineWall Streets Journal - Mar, 4 2020
Recruitment Begins for First Test of Experimental Coronavirus VaccineIn-PharmaTechnologist.com - Jul, 23 2018
Moderna opens manufacturing site in Massachussets to advance its mRNA pipelineBoston Business Journal - Jul, 17 2018
Moderna's $110M Norwood site built with expansion hopesBusiness Wire (press release) - Jul, 17 2018
Moderna Opens New Manufacturing Site in Norwood, MABusiness Wire (press release) - Jul, 11 2018
Moderna Provides Mid-Year Corporate UpdateXconomy - May, 9 2018
Moderna's Billions: Will Building Big Before an IPO Pay Off?Forbes - May, 3 2018
Merck Teams With Moderna To Take On One Of The Toughest Targets In CancerGenetic Engineering & Biotechnology News - Feb, 2 2018
Moderna Raises $500M Financing for mRNA R&D, Manufacturing- Dec, 9 2016
3 Successful Start-Ups That Shun the Spotlight- Oct, 28 2016
Biocon Ranked Among Global Top Ten Biotech EmployersEquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
